Story thread · 2 reports / 2 sources
Leo Pharma Buys Rights to Skin Disease Drug in Latest Deal
bloomberg.com · 4h · first report
How the coverage leans
Across 2 sources · syndicated copies counted once
Leo Pharma A/S agreed to buy the global rights to a drug in late-stage development to treat two rare genetic skin diseases, adding to a series of deals as the Danish drugmaker positions for an initial public offering.
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.